Medical/Pharmaceuticals

Boehringer Ingelheim named Top Employer in Philippines, across Southeast Asia, and South Korea for 2021

MAKATI CITY, Philippines, Jan. 25, 2021 /PRNewswire/ --  Boehringer Ingelheim has been recognized as a Top Employer for 2021 inPhilippines and six other countries acrossAsia - Indonesia, Malaysia, Singapore, South Korea, Thailand and Vietnam - by Top Employers Institute, the global authority on ex...

2021-01-25 10:00 1783

Boehringer Ingelheim named Top Employer in Singapore, across Southeast Asia, and South Korea for 2021

SINGAPORE, Jan. 25, 2021 /PRNewswire/ -- Boehringer Ingelheim has been recognized as a Top Employer for 2021 inSingapore and six other countries across Asia - Indonesia, Malaysia, Philippines, South Korea, Thailand and Vietnam - by Top Employers Institute, the global authority on excellence in peo...

2021-01-25 10:00 2147

Boehringer Ingelheim named Top Employer in Thailand, across Southeast Asia, and South Korea for 2021

BANGKOK, Jan. 25, 2021 /PRNewswire/ -- Boehringer Ingelheim has been recognized as a Top Employer for 2021 inThailand and six other countries across Asia - Indonesia, Malaysia, Philippines, Singapore, South Korea and Vietnam - by Top Employers Institute, the global authority on excellence in peop...

2021-01-25 10:00 1748

Boehringer Ingelheim named Top Employer in Indonesia, across Southeast Asia, and South Korea for 2021

JAKARTA, Indonesia, Jan. 25, 2021 /PRNewswire/ -- Boehringer Ingelheim has been recognized as a Top Employer for 2021 inIndonesia and six other countries across Asia - Malaysia, Philippines, Singapore, South Korea, Thailand and Vietnam - by Top Employers Institute, the global authority on excellen...

2021-01-25 10:00 1844

Antengene Announces Approval of IND Application in China for ATG-010 (Selinexor) in Combination with R-GDP (SR-GDP) for the Treatment of rrDLBCL in a Global Phase 2/3 Study

SHANGHAI and HONG KONG, Jan. 25, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncol...

2021-01-25 08:20 2390

Nanoform's Clinical Study Indicates Positive Interim Results

HELSINKI, Jan. 22, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, today announced positive interim results from its clinical study. The faster absorption data implies that small particles can indeed be powerful. Nanoform has received...

2021-01-22 15:43 1585

Elekta divests its stake in ViewRay

STOCKHOLM, Jan. 22, 2021 /PRNewswire/ -- Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (11,501,597 shares) in ViewRay, Inc. (Nasdaq:VRAY). Elekta has no remaining shares in ViewRay after the transaction. The shares in ViewRay were purchase...

2021-01-22 14:51 4880

GS1 HK and Zenecom join hands to help local merchants seize trillions O2O opportunities in Mainland medical, healthcare and beauty markets

HONG KONG, Jan. 22, 2021 /PRNewswire/ -- GS1 Hong Kong (GS1 HK) and Zenecom International Group Co. Ltd (Zenecom) formally signed a strategic cooperation agreement to launch "HK Trusted Market + WJH" initiative. Capitalising on the cross-border "Big Health" e-commerce platform WJH, the programme ...

2021-01-22 14:25 2216

Nippon Express (China) Inks MOU on Logistics Business Partnership with Jointown Pharmaceutical Group Logistics

TOKYO, Jan. 22, 2021 /PRNewswire/ -- Nippon Express (China) Co., Ltd. (hereinafter "NE China"), a subsidiary of Nippon Express Co., Ltd. of Tokyo, signed a memorandum of understanding (MOU) onDecember 18, 2020, over business partnership with Jointown Pharmaceutical Group Logistics Co., Ltd. (here...

2021-01-22 14:00 2327

DWHP Announces Extension of The Expiration Time of Its Tender Offer

PARK CITY, Utah, Jan. 22, 2021 /PRNewswire/ -- DW Healthcare Partners V, L.P. (" DWHP"), announced today that it is extending the expiration time of its previously announced cash tender offer (the "Tender Offer") in the Offer to Purchase datedDecember 21, 2020 ("Offer to Purchase") for all of the ...

2021-01-22 12:34 9504

Senhwa Announces the First Patient Enrolled in an Investigator Initiated Trial Of Silmitasertib as a Treatment for Patients with Severe COVID-19

TAIPEI and SAN DIEGO, Jan. 21, 2021 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, today announced that the first patient has enrolled into an investi...

2021-01-22 12:00 1607

Menarini Receives European Commission Approval of ELZONRIS (tagraxofusp), for the Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

- ELZONRIS is the first approved treatment for patients with BPDCN, and the first approved CD123-targeted therapy, inEurope - Approval is based on the results of the largest prospective clinical trial ever conducted in patients with treatment-naïve or previously-treated BPDCN FLORENCE, Italy, Ja...

2021-01-22 02:25 2929

AGC Biologics Appoints David Stewart as the New General Manager/Site Head of the Boulder, Colorado Site

BOULDER, Colo., Jan. 22, 2021 /PRNewswire/ -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), has announced a new appointment to oversee the startup, strategic development and operational excellence in large-scale biologics production ...

2021-01-22 02:00 2939

Bactiguard-coated Zimmer Biomet trauma implants receive European regulatory clearance

STOCKHOLM, Jan. 22, 2021 /PRNewswire/ -- Today, Bactiguard-coated Zimmer Biomet orthopaedic trauma implants received European regulatory clearance and CE mark. Preparations for registering the implants in the U.S. market are also ongoing. "I am very pleased that the CE mark has been secured for B...

2021-01-22 01:59 1996

Sasakawa Leprosy (Hansen's Disease) Initiative Generates Awareness in Buildup to World Leprosy Day 2021

TOKYO, Jan. 21, 2021 /PRNewswire/ -- With the approach of World Leprosy Day on January 31, 2021, Sasakawa Leprosy (Hansen's Disease) Initiative has created a number of opportunities to amplify the voices of persons affected by leprosy and highlight the issues they face.

2021-01-21 22:00 1575

China Jo-Jo Drugstores Hosts the First Suppliers Conference in China

HANGZHOU, China, Jan. 21, 2021 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that the...

2021-01-21 21:30 6804

Envirotainer Opens First RAP e2 Station in Taipei

UPPLANDS VÄSBY , Sweden, Jan. 21, 2021 /PRNewswire/ -- Envirotainer, the global market leader and by far the largest provider of secure cold chain solutions for air transport of pharmaceuticals, today announced that they are expanding their network of RAP e2 stations by addingTaipei (TPE) to its ...

2021-01-21 16:14 1958

CPhI & P-MEC China gives a glimpse of the success returning pharma events will deliver in 2021

SHANGHAI, Jan. 21, 2021 /PRNewswire/ -- The recently hosted CPhI & P-MEC China 2020 -- organized by Informa Markets and CCCMHPIE and co-organized by Shanghai Sinoexpo Informa Markets International Exhibition Co., Ltd. -- attracted a remarkable 46,157 visits of professional pharma visitors, includ...

2021-01-21 16:00 2136

Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area

WALTHAM, Mass., Jan. 21, 2021 /PRNewswire/ -- Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site inEurope, announced at the virtual grand opening ceremony o...

2021-01-21 12:35 1324

Seegene to advance business in Latin America in the New Year

SEOUL, South Korea, Jan. 21, 2021 /PRNewswire/ -- South Korea's leading molecular diagnostics firm Seegene Inc. (KQ096530) said Wednesday that it is expanding its business inLatin America in the new year with a strong focus on its multiplex assay product. Seegene said it received an approval f...

2021-01-21 07:56 1400
1 ... 430431432433434435436 ... 578